Description and validation of the apnea risk evaluation system: a novel method to diagnose sleep apnea-hypopnea in the home

ARES had a 0.96 correlation with PSG when recorded concurrently and 0.88 for in-home ARES vs. PSG. ARES demonstrated a sensitivity of 97.4 and a specificity of 85.6 in 284 subjects with data acquired concurrently with PSG, and a sensitivity of 91.5 and a specificity of 85.7 in 187 subjects when comparing in-home recordings to PSG. 32 of 35 of the in-home misclassifications were attributed to differences in the percent time supine. Twenty-percent of the subjects included in this study were healthy controls. The failure rate for the in-home comparisons was only 2%
Description and validation of the apnea risk evaluation system: a novel method to diagnose sleep apnea-hypopnea in the home

More news

Important Message Regarding Hurricane Irma

IMPORTANT MESSAGE FROM SLEEPMED REGARDING HURRICANE IRMA Good afternoon: SleepMed would like to take this opportunity to update our employees and customers on the preparations being made for the potential impact of Hurricane Irma on the Southeast United States. • First – Our thoughts/prayers/support remain with our patients, customers and employees in Houston and all […]

SleepMed and EarlySense announce partnership to broaden sleep apnea detection

http://markets.businessinsider.com/news/stocks/EarlySense-and-SleepMed-Inc-Partner-to-Deliver-Expert-Solutions-for-Sleep-Apnea-Detection-and-Treatment-in-the-Comfort-of-One-s-Home-1002282851